Wisp introduces a new longevity platform offering science-backed treatments designed to support women’s healthy aging, cellular repair, and overall wellness.
Wisp, the largest women-focused telehealth provider in the United States, has announced a significant expansion of its digital healthcare services with the launch of a new Longevity and Healthy Aging category. The initiative marks the company’s first major step into clinician-guided longevity care, an emerging area of medicine that focuses not just on extending lifespan, but on improving health and vitality as people age. With this new offering, Wisp aims to address a long-standing gap in the healthcare and longevity industry—one that has often overlooked the specific biological and hormonal needs of women.
Expanding Women’s Healthcare Beyond Reproductive Needs
For years, much of women’s digital healthcare has centered primarily on reproductive health services, including birth control, fertility support, and treatments for common gynecological conditions. However, Wisp’s latest initiative signals a shift toward a broader and more comprehensive model of women’s health. By introducing longevity-focused treatments and care pathways, the company is expanding its digital care model into what it describes as a “healthspan ecosystem.”
The new category is designed to help women maintain optimal health across different stages of life, particularly as they transition through phases such as perimenopause and menopause. These life stages often bring complex hormonal changes that can affect energy levels, immune function, metabolism, and cognitive health. Yet historically, many longevity products and programs have focused predominantly on male performance optimization rather than female health.
According to Wisp leadership, this imbalance has created a critical need for healthcare solutions that address women’s unique physiology and long-term wellness goals.
Science-Backed Treatments Targeting Cellular Health
The Longevity and Healthy Aging category debuts with five evidence-based treatments designed to support cellular function, immune health, and overall vitality. These treatments include:
- Glutathione (nasal spray and injectable forms)
- NAD+ (nasal spray and injectable forms)
- Low-Dose Naltrexone (LDN)
Each of these therapies targets biological systems associated with aging and chronic health issues.
Glutathione is widely recognized as one of the body’s most powerful antioxidants. It plays a crucial role in protecting cells from oxidative stress, supporting detoxification pathways, and maintaining immune function. As people age, natural glutathione levels tend to decline, which can contribute to fatigue, inflammation, and reduced cellular repair capacity.
NAD+ (nicotinamide adenine dinucleotide) is another critical molecule involved in cellular energy production and metabolic processes. Often associated with mitochondrial health, NAD+ helps fuel the body’s energy systems and supports cellular repair mechanisms. Levels of NAD+ decrease with age, which researchers believe may contribute to fatigue, cognitive decline, and metabolic dysfunction.
Low-dose naltrexone, commonly referred to as LDN, is a therapy that has gained attention for its potential to modulate immune function and reduce inflammation. It has been explored in treatments for autoimmune conditions, chronic pain disorders, and other inflammatory diseases. Because women represent a large proportion of patients diagnosed with autoimmune conditions, LDN may offer a valuable therapeutic option within longevity-focused care.
Together, these treatments aim to optimize biological function by improving cellular repair, restoring energy metabolism, and recalibrating immune responses.
Survey Highlights a Longevity Knowledge Gap
The launch of the new longevity category follows the release of findings from a nationwide survey conducted by Wisp involving nearly 2,000 women. The research revealed a significant disconnect between women’s desire to prioritize long-term health and their access to reliable guidance on longevity interventions.
According to the survey results:
- 75 percent of women reported prioritizing long-term health in their daily lifestyle decisions.
- Nearly half of respondents said they were uncertain about which longevity treatments actually work for women’s bodies.
- 92 percent believed telehealth platforms could play a vital role in supporting healthy aging.
- Only 11 percent felt that existing digital health tools truly gave them a sense of control over their aging and wellness journey.
These findings suggest that while interest in longevity and preventative healthcare is growing rapidly, many women feel underserved by the current ecosystem of wellness products, supplements, and biohacking trends.
Addressing a Male-Dominated Longevity Industry
The broader longevity market has grown dramatically in recent years, fueled by advances in biotechnology, anti-aging research, and a surge of interest in biohacking. However, much of this movement has historically centered around male-centric health goals such as performance optimization, muscle growth, and metabolic enhancement.
This emphasis has often left women’s health concerns—such as hormonal fluctuations, autoimmune disorders, chronic fatigue, and cognitive changes—underrepresented in research and product development.
Women account for approximately 80 percent of autoimmune disease diagnoses, and many experience symptoms such as brain fog, fatigue, and inflammation during hormonal transitions like perimenopause and menopause. Despite these realities, healthcare frameworks in the longevity space have not always accounted for these gender-specific factors.
Monica Cepak, CEO of Wisp, believes this imbalance has created barriers for women seeking accessible and trustworthy longevity care.
“As the telehealth market for treatments like NAD+ and glutathione becomes increasingly fragmented and expensive, women are being left behind,” Cepak explained. “Women are navigating complex hormonal transitions and immune issues that don’t fit into a standard biohacking framework. Our goal is to translate complex science into clear, clinician-guided plans that support women long before symptoms escalate into serious health challenges.”
A New Model of Clinician-Guided Telehealth Care
Wisp’s longevity program integrates several components designed to make preventative healthcare more accessible and personalized for women.
The model includes asynchronous consultations, allowing patients to communicate with healthcare professionals at their convenience without scheduling traditional appointments. This format provides flexibility for individuals balancing busy work schedules, caregiving responsibilities, or other daily commitments.
Patients also receive ongoing clinician oversight, ensuring that treatments are monitored and adjusted based on individual health responses and goals. Personalized treatment plans allow healthcare providers to refine protocols over time as patients progress through different life stages.
Another central feature of the program is its preventative focus. Rather than waiting for disease symptoms to appear, Wisp’s approach emphasizes early intervention and lifecycle-based care. By addressing cellular health, immune balance, and metabolic function earlier in life, the company hopes to help women maintain vitality and resilience well into older age.
Expanding Into Peptides and Advanced Longevity Therapies
The launch also marks Wisp’s entry into the rapidly growing field of peptide-based therapies. Peptides are short chains of amino acids that can influence numerous biological processes, including metabolism, tissue repair, immune signaling, and hormone regulation.
By incorporating peptides into its offerings, Wisp aims to expand its longevity platform beyond individual prescriptions and toward a more comprehensive preventative wellness framework.
Dr. Shannon Chatham, Medical Director at Wisp, emphasized that the company’s approach prioritizes evidence-based medicine rather than trend-driven experimentation.
“We are helping women take control of their healthspan, not just their lifespan,” Chatham said. “This isn’t about chasing trends or adopting every new wellness fad. It’s about providing sustainable, science-backed care that reflects the real needs women face as they age.”